Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georg Maschmeyer

Showing results (11-20 of 97) with videos related to

Pageof 10
Sort By:
Current Infectious Disease Reports|October 28, 2009
New immunosuppressive agents and risk for invasive fungal infectionsGeorg Maschmeyer, Thomas F Patterson
Oncology Research and Treatment|May 8, 2018
Challenges in Infectious Diseases for HaematologistsMarie von Lilienfeld-Toal, Georg Maschmeyer
Cancer Treatment Reviews|April 30, 2026
Management of infections in the outpatient care of patients with cancerMichael Sandherr, Georg Maschmeyer, Christina Rieger
Drugs|July 31, 2007
Invasive aspergillosis: epidemiology, diagnosis and management in immunocompromised patientsGeorg Maschmeyer, Antje Haas, Oliver A Cornely
Expert Review of Anti-Infective Therapy|January 29, 2019
Management of febrile neutropenia in the perspective of antimicrobial de-escalation and discontinuationMartin Schmidt-Hieber, Daniel Teschner, Georg Maschmeyer, et al.
European Journal of Haematology|May 26, 2017
Residual thymic tissue and lymph node involvement by acute myeloid leukaemia presenting as mediastinal, strongly <sup>18</sup> FDG-PET-positive massesGeorg Maschmeyer, Ingo Brink, Doris Jähne, et al.
Oncology Research and Treatment|July 2, 2025
Onkopedia: What's New? Systemic Tumor Treatment in PregnancyGeorg Maschmeyer, Tanja Fehm, Sibylle Loibl, et al.
Medical Mycology|May 16, 2009
Invasive mould infections: a multi-disciplinary updateGeorg Maschmeyer, Thierry Calandra, Nina Singh, et al.
International Journal of Hematology|October 7, 2005
CD52 is not a promising immunotherapy target for most patients with multiple myelomaJörg Westermann, Georg Maschmeyer, Antje van Lessen, et al.
The Journal of Antimicrobial Chemotherapy|August 24, 2016
ECIL guidelines for treatment of Pneumocystis jirovecii pneumonia in non-HIV-infected haematology patientsGeorg Maschmeyer, Jannik Helweg-Larsen, Livio Pagano, et al.
Pageof 10

Showing results (11-20 of 97) with videos related to

Sort By:
Pageof 10
Current Infectious Disease Reports|October 28, 2009
New immunosuppressive agents and risk for invasive fungal infectionsGeorg Maschmeyer, Thomas F Patterson
Oncology Research and Treatment|May 8, 2018
Challenges in Infectious Diseases for HaematologistsMarie von Lilienfeld-Toal, Georg Maschmeyer
Cancer Treatment Reviews|April 30, 2026
Management of infections in the outpatient care of patients with cancerMichael Sandherr, Georg Maschmeyer, Christina Rieger
Drugs|July 31, 2007
Invasive aspergillosis: epidemiology, diagnosis and management in immunocompromised patientsGeorg Maschmeyer, Antje Haas, Oliver A Cornely
Expert Review of Anti-Infective Therapy|January 29, 2019
Management of febrile neutropenia in the perspective of antimicrobial de-escalation and discontinuationMartin Schmidt-Hieber, Daniel Teschner, Georg Maschmeyer, et al.
European Journal of Haematology|May 26, 2017
Residual thymic tissue and lymph node involvement by acute myeloid leukaemia presenting as mediastinal, strongly <sup>18</sup> FDG-PET-positive massesGeorg Maschmeyer, Ingo Brink, Doris Jähne, et al.
Oncology Research and Treatment|July 2, 2025
Onkopedia: What's New? Systemic Tumor Treatment in PregnancyGeorg Maschmeyer, Tanja Fehm, Sibylle Loibl, et al.
Medical Mycology|May 16, 2009
Invasive mould infections: a multi-disciplinary updateGeorg Maschmeyer, Thierry Calandra, Nina Singh, et al.
International Journal of Hematology|October 7, 2005
CD52 is not a promising immunotherapy target for most patients with multiple myelomaJörg Westermann, Georg Maschmeyer, Antje van Lessen, et al.
The Journal of Antimicrobial Chemotherapy|August 24, 2016
ECIL guidelines for treatment of Pneumocystis jirovecii pneumonia in non-HIV-infected haematology patientsGeorg Maschmeyer, Jannik Helweg-Larsen, Livio Pagano, et al.
Pageof 10